Oakmark Goes Globetrotting

Value-investing legend Bill Nygren is at it again. Harris Associates, the parent firm for the Oakmark family of funds, recently issued a prospectus for OakmarkGlobal Select, a new fund that will be led by Nygren and colleague David Herro. It aims to thrash the market by buying foreign equities on the cheap. Should you be interested? Read on to find out.

Nygren is an expert value investor who buys stocks for what he calculates to be less than their true worth. For example, current top holdings in his OakmarkSelect fund include Washington Mutual (NYSE: WM  ) and Pulte Homes (NYSE: PHM  ) -- both of which trade for below market-average P/Es.

What's more, Nygren has a solid track record as a fund manager. The Oakmark funds he manages with Kevin Grant and Henry Berghoef have racked up solid gains:





Top Holdings





Washington Mutual;
McDonald's (NYSE: MCD  )





Washington Mutual;
YUM! Brands (NYSE: YUM  )

Source: Oakmark

But Global Select is going to focus on international equities, which is Herro's specialty. Like Nygren, he's also posted a solid track record at the two funds he manages:


1-year return

5-year return

10-year return

Top Holdings





GlaxoSmithKline (NYSE: GSK  ) ;
British Sky Broadcasting

Small Cap




Julius Baer Holding;
JJB Sports

Source: Oakmark

What to watch
I've yet to get through the entire Oakmark Global Select prospectus, but a few things stick out from what I've read thus far:

  • It won't take undue risks. Global Select is going to give itself the flexibility to hold as much as 75% of its assets in U.S. equities, and plans to limit investments in emerging market to 15% of assets.
  • It will invest defensively. Nygren and Herro write that, from time to time, they may wish to invest in high-quality debt, money market securities, and cash.
  • It will be expensive to begin with. Classically, Oakmark funds have been a terrific value. Take Nygren's Oakmark fund; it charges only 1.07% annually. And Herro's International fund also sports a miniaturized 1.09% per year. Global Select, on the other hand, will likely begin much higher, at 1.75% for class I shares. Expect this ratio to decline as the fund adds money.

Invest with champions
With proven managers at the helm, Oakmark Global Select has the makings of a championship-caliber mutual fund -- as long as its expense ratio comes down a bit. Because as Fool fund guru Shannon Zimmerman likes to say, "With funds, you often get what you don't pay for."

If you'd like to learn more about superior mutual funds with low expense ratios, consider joining our Champion Funds service free for 30 days. The picks are beating their benchmarks by more than eight percentage points, and Shannon's model portfolios can help you transform your holdings into a market-thumping mix of funds. Click here to get started.

Fool contributor Tim Beyers is still a stock jock, but he's liking funds more and more every day. Tim didn't own shares in any of the companies or funds mentioned in this story at the time of publication. You can find out what is in his portfolio by checking Tim's Fool profile. Oakmark I is a Motley Fool Champion Funds selection. GlaxoSmithKline is an Income Investor recommendation. The Motley Fool has an ironcladdisclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 506446, ~/Articles/ArticleHandler.aspx, 12/1/2015 1:55:54 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Tim Beyers

Tim Beyers first began writing for the Fool in 2003. Today, he's an analyst for Motley Fool Rule Breakers and Motley Fool Supernova. At, he covers disruptive ideas in technology and entertainment, though you'll most often find him writing and talking about the business of comics. Find him online at or send email to For more insights, follow Tim on Google+ and Twitter.

Today's Market

updated Moments ago Sponsored by:
DOW 17,819.14 99.22 0.56%
S&P 500 2,091.61 11.20 0.54%
NASD 5,131.40 22.73 0.44%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/1/2015 1:39 PM
GSK $40.77 Up +0.26 +0.64%
GlaxoSmithKline CAPS Rating: ****
MCD $114.25 Up +0.09 +0.08%
McDonald's CAPS Rating: ***
PHM $19.56 Up +0.08 +0.41%
PulteGroup, Inc. CAPS Rating: ***
WAMUQ.DL $0.00 Down +0.00 +0.00%
Washington Mutual,… CAPS Rating: No stars
YUM $74.35 Up +1.84 +2.54%
Yum! Brands CAPS Rating: ****